Royal Bank of Canada’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $91K | Sell |
|
|||||
|
2025
Q2 | $135K | Buy |
|
|||||
|
2025
Q1 | $18K | Sell |
|
|||||
|
2024
Q4 | $178K | Buy |
|
|||||
|
2024
Q3 | $274K | Buy |
|
|||||
|
2024
Q2 | $208K | Buy |
|
|||||
|
2024
Q1 | $166K | Sell |
|
|||||
|
2023
Q4 | $355K | Buy |
|
|||||
|
2023
Q3 | $164K | Sell |
|
|||||
|
2023
Q2 | $206K | Buy |
|
|||||
|
2023
Q1 | $102K | Sell |
|
|||||
|
2022
Q4 | $143K | Buy |
|
|||||
|
2022
Q3 | $18K | Buy |
|
|||||
|
2022
Q2 | $10K | Sell |
|
|||||
|
2022
Q1 | $67K | Sell |
|
|||||
|
2021
Q4 | $215K | Buy |
|
|||||
|
2021
Q3 | $57K | Buy |
|
|||||
|
2021
Q2 | $49K | Sell |
|
|||||
|
2021
Q1 | $79K | Buy |
|
|||||
|
2020
Q4 | $31K | Buy |
|
|||||
|
2020
Q3 | $4K | Buy |
|
|||||
|
2020
Q2 | $4K | Buy |
|